Revive Therapeutics Ltd. (CSE:RVV)
Canada · Delayed Price · Currency is CAD 0.0200
0.00 (0.00%)
Sep 18, 2026, 2:36 PM EST
Revive Therapeutics Cash Flow Statement
Financials in millions CAD. Fiscal year is July - June.
Millions CAD. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Income | -10.62 | -11.01 | -5.62 | -6.32 | -17.81 | -20.12 |
Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 |
Asset Writedown & Restructuring Costs | 9.38 | 9.38 | 2.34 | 0.78 | - | - |
Loss (Gain) From Sale of Investments | 0 | 0.01 | 0.05 | 0.09 | - | -0.18 |
Stock-Based Compensation | 0.51 | 0.32 | 0.14 | - | 1.04 | 8.57 |
Other Operating Activities | -0.06 | -0.07 | -0.01 | 0.18 | 0.17 | 2.72 |
Change in Accounts Payable | 0.69 | 0.29 | 0.04 | -0.76 | 3.58 | 0.21 |
Change in Other Net Operating Assets | -0.06 | 0.31 | -0.23 | 0.01 | -0.03 | 0.5 |
Operating Cash Flow | -0.16 | -0.77 | -3.29 | -6.03 | -13.06 | -8.31 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Sale (Purchase) of Intangibles | - | - | - | - | - | -3 |
Investment in Securities | - | -0.03 | - | - | - | 0.28 |
Investing Cash Flow | - | -0.03 | - | - | - | -2.72 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Long-Term Debt Issued | - | 0.07 | - | - | - | 0.02 |
Total Debt Issued | - | 0.07 | - | - | - | 0.02 |
Long-Term Debt Repaid | - | -0.03 | -0.19 | -0.15 | -0.15 | -0.15 |
Lease Payments | - | -0.03 | -0.15 | -0.15 | -0.15 | -0.15 |
Net Debt Issued (Repaid) | - | 0.04 | -0.19 | -0.15 | -0.15 | -0.13 |
Issuance of Common Stock | 0.15 | - | 2.1 | 4.59 | 0.38 | 28.67 |
Other Financing Activities | -0.03 | - | 0.07 | -0.24 | 0.15 | -2.3 |
Financing Cash Flow | 0.12 | 0.04 | 1.98 | 4.2 | 0.38 | 26.24 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Cash Flow | -0.03 | -0.76 | -1.31 | -1.83 | -12.68 | 15.22 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Free Cash Flow | -0.16 | -0.77 | -3.29 | -6.03 | -13.06 | -8.31 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | - | -0.00 | -0.01 | -0.02 | -0.04 | -0.03 |
Levered Free Cash Flow | 0.24 | -0.18 | -2.04 | -4.25 | -6.66 | -5.4 |
Unlevered Free Cash Flow | 0.24 | -0.18 | -2.02 | -4.23 | -6.62 | -5.35 |
Free Cash Flow After Leases | -0.16 | -0.79 | -3.45 | -6.18 | -13.21 | -8.46 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Change in Working Capital | 0.63 | 0.6 | -0.19 | -0.75 | 3.54 | 0.71 |